Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05122728 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-Concussion Musculoskeletal Injury Risks

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 27, 2026 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2024 to Sep 30, 2026
    • Study completion date: Dec 1, 2025 to Sep 30, 2027
    v7
  2. Re-verified, no change to tracked fieldsv6
  3. Trial status: Not Yet Recruiting to Recruitingv5 Show 4 more changesShow less
    • Start date changed from estimate of Sep 1, 2022 to Oct 20, 2022
    • Eligibility criteria expanded, about 27 words
    • Study description revised
    • Site details revised at 3 of 3 sites
  4. Start date: Jul 1, 2022 to Sep 1, 2022v4
  5. Primary endpoints revised (17)
    • Eligibility criteria expanded, about 57 words
    • Study description expanded, about 24 words
    v3
  6. Start date: Jan 1, 2022 to Jul 1, 2022v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Musculoskeletal injuries (MSKI) and traumatic brain injury (TBI) are the signature injuries of the ongoing military conflicts. MSKI affect 800,000 Service Members annually and TBI have impacted more than 350,000 in the past 19 years and account for 22% of all combat casualties. Concussion, a mild form of TBI, increases MSKI risk in physically active individuals, including Service Members. The overall goal of the study is to identify the neuromuscular control mechanisms that increase MSKI risk following concussion. It is hypothesized that concussed individuals will display abnormal neuromuscular function that increases MSKI risk, as compared to non-concussed controls. The study will employ a multi-center, prospective, case-matched control observational study to identify the differences in neuromuscular function following concussion that may contribute to increased MSKI risk. Once the neuromuscular control mechanisms that increase MSKI risk following concussion are identified, targeted risk mitigation strategies can be developed to reduce MSKI risk.
Trial Details
NCT Number NCT05122728
Lead Sponsor Walter Reed National Military Medical Center
Collaborators: Womack Army Medical Center, University of Georgia
Conditions
(from sponsor)		 Musculoskeletal Injury
Related terms Brain Concussion, Brain Injuries, Traumatic
Enrollment 148 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov